Home › Migraine › Michigan
Migraine clinical trials in Michigan
6 studies for Migraine are looking for participants at sites in Michigan.
Cities in Michigan
Study of EVO756 in Adults With Migraine
- Michigan Headache and Neurological Institute, Ann Arbor
- Quest Research Institute-Alcanza, Farmington Hills
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Oct 2, 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NRST - Detroit, Detroit
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Michigan Head Pain and Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Michigan Head Pain & Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Michigan Headache Pain & Neurological Institute, Ann Arbor
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.